Next-Generation Sequencing of Hematologic Neoplasms
This video lecture will focus on next-generation sequencing (NGS)-based tests in hematologic neoplasms, particularly the clinical utility of this technology and how it is revolutionizing the management of patients with hematologic neoplasms. The design and development of NGS tests, including a basic overview of a test pipeline with both laboratory and informatics components, will also be discussed.
Originally presented on December 17, 2015 in Salt Lake City, Utah.
Todd Kelley, MD
Medical Director, Hematopathology and Molecular Hematopathology Laboratories, ARUP Laboratories
Associate Professor of Pathology, University of Utah School of Medicine
Dr. Kelley is an associate professor in the Department of Pathology at the University of Utah. He received his MS in immunology and microbiology and his MD from Ohio State University, and completed his residency in anatomic and clinical pathology and fellowship training in hematopathology at the Cleveland Clinic. He is board certified in anatomic and clinical pathology by the American Board of Pathology, with subspecialty certification in hematology. His research interests include the identification of novel diagnostic and prognostic biomarkers in leukemia and lymphoma.
After this presentation, participants will be able to:
- List the components of a NGS pipeline for testing of hematologic neoplasms.
- Describe the clinical utility of NGS technology in the context of testing of hematologic neoplasms.
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories